Key result
Deprescribing BP medications in hypotensive syncope is linked to a ~66% reduction in syncope burden.
Why the study?
The study assessed the efficacy of deprescribing blood pressure-lowering medications in hypertensive patients suffering from severe hypotensive syncope.
Does deprescribing blood pressure-lowering medications reduce the burden of syncope in hypertensive patients with severe hypotensive syncope?
Cohort (n=92)
Yes
Does deprescribing blood pressure-lowering medications reduce the burden of syncope in hypertensive patients with severe hypotensive syncope?
Deprescribing blood pressure-lowering medications in hypertensive patients with hypotensive syncope significantly reduced the burden of syncopal episodes.
Answers are grounded in this paper and cite their sources.
Should not yet change practice in hypotensive syncope; leaves open deprescribing efficacy pending randomized trials.
AIM: To assess the efficacy of deprescribing blood pressure-lowering medications in hypertensive patients suffering from severe hypotensive syncope. METHOD: Multicentre, prospective, pragmatic, non-randomized uncontrolled, study. Deprescribing (withdrawal or dose reduction of antihypertensive and psychoactive medications with blood pressure lowering effects) was guided by clinical experience and supported by two 24-hour ambulatory blood pressure monitoring (ABPM) assessments-one before (ABPM 1) and one after (ABPM 2) drug optimization. Primary endpoint was the reduction of the burden of syncope. RESULTS: In a cohort of 92 patients (mean age 76.6 ± 12.1 years, 53% female), the total number of hypotensive medications decreased from 218 (2.4 ± 1.1 per patient) before deprescribing to 123 (1.3 ± 1.0 per patient) after the intervention. The 24-hour systolic blood pressure increased from 118.8 ± 10.8 mmHg at ABPM 1 to 127.5 ± 11.6 at ABPM 2 (p = 0.0001). The number of daytime SBP drops <90 mmHg and <100 mmHg decreased by 52%, (from 208 to 100) and 53% (from 601 to 280), respectively (p = 0.0001 for both). During the mean follow-up of 12.6 ± 3.8 months (range 2 to 21 months), 28 patients (30.4%) had syncopal recurrences. Excluding the index episode, patients experienced 111 episodes in the year before enrolment and 41 during the overall follow-up. The syncope burden dropped by 66%, from 0.08 (IQR 0-0.17) to 0 (IQR 0-0.07) episodes per month (p = 0.0001). CONCLUSION: In patients with hypertension and hypotensive syncope deprescribing of blood pressure lowering medications reduced hypotensive episodes and syncopal recurrences. However, the findings preclude firm causal inferences.
No takes yet. Share an insight, caveat, or question.
Russo et al. (2026) conducted a cohort in Hypertension with severe hypotensive syncope (n=92). Deprescribing of blood pressure-lowering medications vs. Baseline (before deprescribing) was evaluated on Reduction of the burden of syncope (66% reduction, p=0.0001). Deprescribing blood pressure-lowering medications in patients with hypotensive syncope reduced the syncope burden by 66%, from 0.08 to 0 episodes per month.
Synapse has enriched 10 related papers. Consider them for comparative context: